Detection of benign hilar bile duct stenoses - A retrospective analysis in 250 patients with suspicion of Klatskin tumour

Abstract

IntroductionThe aim of this study was to identify clinical, laboratory and radiological parameters to distinguish benign from malignant stenoses of the proximal bile duct.MethodsBetween 1997 and 2011, 250 patients were referred to our clinic with hilar bile duct stenoses suspicious for Klatskin tumour. Medical histories, clinical data, pre-interventional laboratory tests, imaging findings, as well as therapeutic approach and patient outcome were compared to final histological results. All data were retrieved from our prospectively maintained database and analysed retrospectively.ResultsWe found benign bile duct lesions in 34 patients (13.6%). Among the entire study population, uni- and multivariate analyses of 18 clinicopathological parameters revealed that patient age, serum alkaline phosphatase, tumour marker CA19-9 and presence of tumour mass in computed tomography were independent predictors for malignant biliary stenoses (p < 0.05). Receiver operator characteristic curve showed that a CA19-9 serum level of 61.2 U/ml or more has a sensitivity, specificity and diagnostic accuracy for predicting the malignant nature of the hilar biliary stenoses of 74.6%, 80.0% and 83.5%, respectively. Surgical resection could be avoided by preoperative work-up and surgical exploration in 10 out of 34 patients with benign lesions. Rates of major liver resections performed were 66.7% in the benign lesion group and 90.7% in the Klatskin tumour group.ConclusionDespite improvements of preoperative diagnostics, it remains difficult to differentiate between benign and malignant hilar bile duct stenosis. Even explorative laparotomy was not able to safely exclude Klatskin tumour in all cases and therefore major liver resection was inevitable.

Biliary Strictures and Cholangiocarcinoma – Untangling a Diagnostic Conundrum

“…Surgical resection of pCCA is guided by the Bismuth-Corlette classification (30) with types II-IV requiring extensive surgery which involves major hepatic resection in the form of extended hepatectomy and caudate lobectomy (Figure 1) (29,31). Reports of up to 25% of patients who underwent surgical resection for suspected CCA and subsequently found to have benign disease, highlight an urgent need for more accurate diagnostics (32)(33)(34). A diagnostic modality with improved sensitivity over standard cytology and histology, may therefore prevent unnecessary extensive surgery which has been linked with morbidity and mortality rates as high as 60% and 18%, respectively (29,35).…”

The endoscopist and malignant and non-malignant biliary obstruction

“…Because of the diagnostic difficulties sometimes encountered, definitive treatment such as surgery or chemotherapy may be delayed or given incorrectly, with potential consequences for patients. In one study of 238 patients undergoing surgical resection of suspected cholangiocarcinoma, 13% were found to have benign disease (1). Many of these patients have an autoimmune cholangiopathy (including IgG4-related disease) which can be effectively treated with steroids and other immunosuppressives.…”

Biliary strictures: endoscopic assessment and management

“…A recent study found 13.6% of patients undergoing surgical resection for a suspected Klatskin tumour had benign disease. 2 Such major surgery is associated with appreciable morbidity and not insignificant morbidity. Therefore, confirming the diagnosis before surgery is preferable.…”